Quantbot Technologies LP grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 223.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,144 shares of the company's stock after buying an additional 13,217 shares during the quarter. Quantbot Technologies LP's holdings in Molina Healthcare were worth $5,572,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently made changes to their positions in the stock. True Wealth Design LLC boosted its stake in Molina Healthcare by 2,500.0% during the third quarter. True Wealth Design LLC now owns 104 shares of the company's stock valued at $36,000 after buying an additional 100 shares in the last quarter. Versant Capital Management Inc lifted its holdings in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after acquiring an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. bought a new position in shares of Molina Healthcare during the 4th quarter valued at about $52,000. EverSource Wealth Advisors LLC grew its stake in shares of Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Molina Healthcare by 337.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after purchasing an additional 155 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Stock Up 4.3 %
MOH stock traded up $13.45 during trading hours on Wednesday, hitting $323.98. The company's stock had a trading volume of 534,473 shares, compared to its average volume of 612,715. The company has a market capitalization of $17.72 billion, a PE ratio of 15.86, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56. The stock has a 50 day moving average price of $300.69 and a two-hundred day moving average price of $308.97. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $423.92.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, equities research analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.10% of the stock is owned by company insiders.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. StockNews.com lowered Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Monday, March 10th. Mizuho decreased their price target on Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. UBS Group decreased their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Finally, Stephens restated an "equal weight" rating and set a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $355.69.
Read Our Latest Analysis on Molina Healthcare
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.